News

Ligand Pharmaceuticals Incorporated (Ligand) announced the signing of a definitive merger agreement with Avista Public Acquisition Corp. II, a publicly traded special purpose…
Read More...

Cyclica Inc. a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline, and Arctoris Ltd. (“Arctoris”), a tech-enabled biopharma company that…
Read More...

LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, today announced the…
Read More...

Quest Diagnostics announced that it has been granted a contract by the Centers for Disease Control and Prevention (CDC) to perform testing and provide laboratory data analysis to help…
Read More...

LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, announced a strategic R&D…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII),…
Read More...

Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic driver mutations, announced the completion of an oversubscribed $175 million…
Read More...

Acasti Pharma Inc. announces the following patent notifications and awards relating to the Company’s three lead drug candidates: The European Patent Office has provided notice of…
Read More...

Pfizer Inc. announced an agreement with UNICEF to supply up to 4 million treatment courses of its COVID-19 oral treatment, PAXLOVID (nirmatrelvir tablets and ritonavir tablets), to 95…
Read More...

Proscia, a leader in digital and computational pathology solutions, and Visiopharm, a world leader in AI-driven precision pathology software, today announced a strategic partnership to…
Read More...

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel combination therapy,…
Read More...

Merck announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as a single agent for the treatment of patients with advanced…
Read More...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. and its affiliates, has reached an agreement with the Attorney General of Rhode Island that settles the…
Read More...

Wockhardt UK announced a collaboration with Serum Life Sciences UK, a subsidiary of Serum Institute of India, the world’s largest vaccine manufacturer, to deliver a global vaccine…
Read More...

NeuroSense Therapeutics Ltd. announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a pharmacokinetic study of PrimeC in healthy adult…
Read More...

Saniona a clinical stage biopharmaceutical company focused on rare diseases, today announced that its ongoing ion channel research collaboration with Boehringer Ingelheim has advanced …
Read More...

NICE has published final draft guidance recommending elosulfase alfa (also called Vimizin and made by BioMarin) for routine use in the NHS for the treatment of mucopolysaccharidosis…
Read More...

Bristol Myers Squibb announced that Opdualag (nivolumab and relatlimab-rmbw), a new,  first-in-class, fixed-dose combination of nivolumab and relatlimab, administered as a single…
Read More...

Centogene N.V. a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced an expansion of the Company’s data…
Read More...

On March 18, 2022, Lynk Pharmaceuticals Co., Ltd. and Simcere announced a strategic partnership to develop and commercialize a highly selective JAK1 inhibitor LNK01001 in China.…
Read More...